India Globalization Capital, Inc. (NYSE: IGC) Could Release Potential Blockbuster Alzheimer’s Treatment in Early 2018

  • On the verge of releasing potential Cannabis-based blockbuster Alzheimer’s treatment
  • Company is able to hugely accelerate release of this treatment in recreational cannabis states
  • Market potential for drugs to treat and prevent Alzheimer’s is in the billions of dollars

According to information from the Alzheimer’s Association, approximately 47 million people are living with dementia throughout the world—a figure that has been projected to rise to 76 million by 2030. There is still no cure for this devastating disease. However, India Globalization Capital, Inc. (NYSE MKT: IGC) is on the precipice of bringing a potential blockbuster treatment for Alzheimer’s to the market—an event that could happen by early 2018.

Recently, IGC announced it is readying a line of cannabis-based products targeting Alzheimer’s disease based on novel data (http://cnw.fm/0pACN). The company has been engineering genetic cell lines that show the protein Aβ decreases by as much as 40 percent at various concentrations of tetrahydrocannabinol (THC) without…

Read More >>

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Leave a Reply